Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results

T P Hughes; B Leber; F Cervantes; N Spector; R Pasquini; N C D Clementino; A P Schwarer; P E Dorlhiac-Llacer; F-X Mahon; D Rea; A Guerci-Bresler; S Kamel-Reid; I Bendit; S Acharya; T Glynos; D Dalal; S Branford; J H Lipton

doi:10.1038/leu.2017.247

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results

T P Hughes, B Leber, F Cervantes, N Spector, R Pasquini, N C D Clementino, A P Schwarer, P E Dorlhiac-Llacer, F-X Mahon, D Rea, A Guerci-Bresler, S Kamel-Reid, I Bendit, S Acharya, T Glynos, D Dalal, S Branford, J H Lipton

Cancer

Research output: Contribution to journal › Article

24 Citations (Scopus)

Original language	English
Journal	Leukemia
DOIs	https://doi.org/10.1038/leu.2017.247
Publication status	E-pub ahead of print - 3 Aug 2017

Keywords

Journal Article

Access to Document

10.1038/leu.2017.247

Cite this

Hughes, T P ; Leber, B ; Cervantes, F ; Spector, N ; Pasquini, R ; Clementino, N C D ; Schwarer, A P ; Dorlhiac-Llacer, P E ; Mahon, F-X ; Rea, D ; Guerci-Bresler, A ; Kamel-Reid, S ; Bendit, I ; Acharya, S ; Glynos, T ; Dalal, D ; Branford, S ; Lipton, J H. / Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib : final ENESTcmr randomized trial results. In: Leukemia. 2017.

@article{c0cd99d7bed3495f9d6844e5f2efd463,

title = "Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results",

keywords = "Journal Article",

author = "Hughes, {T P} and B Leber and F Cervantes and N Spector and R Pasquini and Clementino, {N C D} and Schwarer, {A P} and Dorlhiac-Llacer, {P E} and F-X Mahon and D Rea and A Guerci-Bresler and S Kamel-Reid and I Bendit and S Acharya and T Glynos and D Dalal and S Branford and Lipton, {J H}",

year = "2017",

month = "8",

day = "3",

doi = "10.1038/leu.2017.247",

language = "English",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

}

Hughes, TP, Leber, B, Cervantes, F, Spector, N, Pasquini, R, Clementino, NCD, Schwarer, AP, Dorlhiac-Llacer, PE, Mahon, F-X, Rea, D, Guerci-Bresler, A, Kamel-Reid, S, Bendit, I, Acharya, S, Glynos, T, Dalal, D, Branford, S & Lipton, JH 2017, 'Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results', Leukemia. https://doi.org/10.1038/leu.2017.247

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib : final ENESTcmr randomized trial results. / Hughes, T P; Leber, B; Cervantes, F; Spector, N; Pasquini, R; Clementino, N C D; Schwarer, A P; Dorlhiac-Llacer, P E; Mahon, F-X; Rea, D; Guerci-Bresler, A; Kamel-Reid, S; Bendit, I; Acharya, S; Glynos, T; Dalal, D; Branford, S; Lipton, J H.

In: Leukemia, 03.08.2017.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib

T2 - final ENESTcmr randomized trial results

AU - Hughes, T P

AU - Leber, B

AU - Cervantes, F

AU - Spector, N

AU - Pasquini, R

AU - Clementino, N C D

AU - Schwarer, A P

AU - Dorlhiac-Llacer, P E

AU - Mahon, F-X

AU - Rea, D

AU - Guerci-Bresler, A

AU - Kamel-Reid, S

AU - Bendit, I

AU - Acharya, S

AU - Glynos, T

AU - Dalal, D

AU - Branford, S

AU - Lipton, J H

PY - 2017/8/3

Y1 - 2017/8/3

KW - Journal Article

U2 - 10.1038/leu.2017.247

DO - 10.1038/leu.2017.247

M3 - Article

C2 - 28862704

JO - Leukemia

JF - Leukemia

SN - 0887-6924

ER -